Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Viral Sentry AI-Automated zoonotic surveillance and drug repurposing agent.

Biology methods & protocols·2026
Same author

Rambutan (<i>Nephelium lappaceum</i> L.) Shell as a Source of Polyphenols: Chemical Characterization and Biological Activities.

Molecules (Basel, Switzerland)·2026
Same author

Monoterpenoid-ciprofloxacin hybrids as a strategy to disrupt Staphylococcus aureus biofilms and overcome associated resistance.

Journal of advanced research·2026
Same author

Tolcapone-loaded nanostructured lipid carriers for improved oral delivery.

International journal of pharmaceutics·2026
Same author

Chromones as Nonclassical Inhibitors of Carbonic Anhydrase IX and XII Isoforms: Probing Chromone-Based Derivatives.

Archiv der Pharmazie·2026
Same author

Hydroxycinnamic and Hydroxybenzoic-Based Mitochondriotropic Antioxidants Improve Bovine Embryo Quality and Cryo-Survival.

Veterinary sciences·2026

Related Experiment Video

Updated: May 24, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Desirability-based multi-objective QSAR in drug discovery.

Maykel Cruz-Monteagudo1, M Natalia D S Cordeiro, Eduardo Tejera

  • 1Departamento de Química, FCUP, Rua do Campo Alegre, 687, 4169-007 Porto, Portugal. maikelcm@uclv.edu.cu

Mini Reviews in Medicinal Chemistry
|March 17, 2012
PubMed
Summary

This study reviews the MOOP-DESIRE methodology, a multi-objective quantitative structure-activity relationship (QSAR) approach for drug discovery. It enables simultaneous optimization of multiple drug properties early in the hit-to-lead identification and lead optimization stages.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Experiment Videos

Last Updated: May 24, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Area of Science:

  • Medicinal Chemistry
  • Chemoinformatics
  • Drug Discovery

Background:

  • Optimizing multiple drug properties simultaneously is crucial for efficient drug discovery.
  • Handling conflicting criteria during hit-to-lead identification and lead optimization presents a significant challenge.
  • There is a need for advanced methods to address these complex optimization tasks early in the drug development pipeline.

Purpose of the Study:

  • To review the MOOP-DESIRE methodology, a desirability-based multi-objective quantitative structure-activity relationship (QSAR) approach.
  • To highlight its capability in jointly handling multiple properties relevant to drug candidates.
  • To assess its suitability for key chemoinformatics tasks in medicinal chemistry and drug discovery.

Main Methods:

  • The MOOP-DESIRE methodology adapts desirability theory concepts.
  • It allows for the holistic modeling of multiple, often conflicting, biological properties.
  • This approach facilitates the simultaneous treatment of key properties determining a drug candidate's pharmaceutical profile.

Main Results:

  • The methodology provides a framework for integrated multi-objective optimization in drug discovery.
  • It enables the consideration of various conflicting properties early in the development process.
  • The review surveys the methodology's applicability to essential chemoinformatics tasks.

Conclusions:

  • The MOOP-DESIRE methodology offers a powerful tool for addressing multi-objective challenges in drug discovery.
  • Its application can lead to more efficient hit-to-lead identification and lead optimization.
  • This approach supports the development of drug candidates with improved pharmaceutical profiles.